AGTR1 and systemic sclerosis: Considering the fact that the functionally active anti-AT1R antibodies measured by the bioassay did not correlate with disease activity and manifestations of SSc and were found also in patients with other disorders, their pathogenic and clinical relevance for SSc remains, questionable.